As used in this Current Report on Form 8-K, and unless otherwise indicated, the terms “the Registrant”, “the Company,” “Organicell,” “we,” “us” and “our” refer to Organicell Regenerative Medicine, Inc.
Item 8.01 Other Events.
On May 4, 2021, Organicell issued a press release in which it announced that it is currently exploring options to up-list its common stock to the NASDAQ Capital Market tier of the NASDAQ Stock Market, LLC.
A copy of the Company’s press release dated May 4, 2021 is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
Exhibit No Description 99.1 Press Release, dated May 4, 2021
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: May 4, 2021 ORGANICELL REGENERATIVE MEDICINE, INC.
By: /s/ Ian Bothwell Ian Bothwell Chief Financial Officer